Associate Director Supply Chain Gene Therapy
Basel - Switzerland
Job Summary
ultracurious Apply your biggest ideas in courageous ways
Theroleisresponsible for leadingtheregionalcommercialSales Inventory and Operations Planning (SIOP) process and supply readiness for newcountry launchesor changes to our Gene Therapy portfolio.The role overseessupply readiness and distributionfromthe production sites (US & Europe)to the end-customers andensures uninterrupted supply through effective cross-functional collaboration inventory management and risk mitigation.
Flex: This role will typically require onsite work 2-3 days each week or more depending on business many locations the business will set certain days each week that Flex employees are required to be onsite.
- Lead Gene Therapy regionalSIOP processusing Kinaxis and Oracle.
- Directlaunchesandproductlifecyclechangesin global cross-functional teams(Quality Regulatory Global Planning Global Packaging Distribution Country Representative) including project management and owning the respectivechange controlsin our Quality Management System.
- Define Countrypackaging configurationsfor newlaunchcountries in close collaboration with Global Packaging Regulatoryand Global Planning and the markets.
- OverseeDistribution Operationsfrom Packaging Sites in the US and Europe direct to the hospitals in partnership withQuality Manufacturing Commercial FinanceandGlobal includes thehandlingofdeviations and respective CAPAimplementation.
- Manage KPIs operationalreviewsand continuous improvement initiatives.
- Provide back-up support for planning activities and flex support for Distribution and Shipping Operationsfor standard modalities.
- Act as keySMEduringaudits/inspectionsfor the gene therapy portfolio.
- Bachelors Degree in Supply Chain Business Engineering LifeSciencesor relatedfield.
- 812years of progressive supply chain experience in aGxP-regulated pharmaceutical or biotechnology environment;experience supporting Gene Therapypreferred.
- Deep knowledge of end-to-end supply chain processesin complex supply networks includingexternal manufacturing.
- Strong understanding of pharmaceutical industry procedures and regulations includingcGMPscGDPand other regulatory requirements.
- Experienceinmanaging complex projects especially product launches across multiple countries.
- Soundknowledge ofglobal distributionandtrade compliancefor high value products.
- Effective communication &stakeholder managementatdifferent levels: verbal written and presentationsin English language strong preference forproficiencyin GermanandFrench language.
- Experience with Kinaxis Oracle ERPMicrosoft Office tools andSmartSheet.
- Experience working within global cross-functional teams and influencing stakeholders across multipleregions.
- Ability to perform effectively in a dynamic environment with changing priorities.
- Ability to travel internationally (up to 10%)
#LI-CK1 #LI-Hybrid
Ultragenyx Pharmaceutical is an equal opportunity employer and prohibits unlawful discrimination based on race color religion gender sexual orientation gender identity/expression national origin/ancestry age disability marital and veteran status and any other status or classification protected by applicable federal state and/or local laws. Reasonable accommodation will be provided for all protected statuses or classifications protected by applicable law including individuals with disabilities disabled veterans for pregnancy childbirth and related medical conditions and based on sincerely held religious beliefs. Applicants can request an accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application or in any part of the recruitment process you may contact Talent Acquisition by emailing us at .
It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability.
Required Experience:
Director
About Company
Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.